Date: 2nd June 2021 at 6:42pm
Written by:

Mikel Arteta’s first season as Arsenal manager has been plagued by individual errors and sloppiness, as the Gunners missed out on European football for the first time in 25 years. 

While there have been flashes of brilliance and many bright sparks in the form of Emile Smith Rowe, Bukayo Saka and Gabriel Martinelli; the Gunners have struggled immensely with many even questioning Arteta’s position as manager.

A rebuild is likely coming to the Emirates and it appears the spine of the team will be the likes of Saka and Smith Rowe, while the jury is still out on Thomas Partey who had struggled with injuries.

However, according to reports from Dutch outlet NUS, Arteta is set to alter the spine of his team by signing Ajax goalkeeper Andre Onana.

Onana has starred for Ajax since 2015.

The 25-year-old goalkeeper has been an impressive presence between Ajax’s sticks and was crucial to the Dutch side’s run to the Champions League semi-final in the 2018/19 season.

However, the Cameroon international was suspended for 12 months in February after a drug test showed he had the banned substance of Furosemide.

The shot stopper has appealed the decision claiming the substance entered his body after he mistakenly took his partner’s medication instead of his.

There is every chance his ban could be reduced in time for next season, and if this is the case, it is reported Arteta is keen to add Onana to his squad.

Arsenal currently have German international Bernd Leno as their number one goalkeeper, and while the former Bayer Leverkusen goalkeeper has been selected for the Euros, he has been prone to errors at the back.

Onana is still young for a goalkeeper and is also well known for his abilities with the ball at his feet – a critical skill for this Arsenal side who choose to play out from the back more often than not.

According to the Dutch outlet, Onana could also be available for as little as £1.7 million, a bargain considering his experience, talent and age.

 
Brought to you by Shoot!

Comments are closed.